Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Burchett

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|May 8, 2015
Pharmacokinetics of Once Versus Twice Daily Darunavir in Pregnant HIV-Infected WomenAlice Stek, Brookie M Best, Jiajia Wang, et al.
The Journal of Infectious Diseases|December 1, 1996
Application of the polymerase chain reaction to the diagnosis and management of neonatal herpes simplex virus disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study GroupD W Kimberlin, F D Lakeman, A M Arvin, et al.
Lancet (London, England)|December 31, 2003
Long-term effects of protease-inhibitor-based combination therapy on CD4 T-cell recovery in HIV-1-infected children and adolescentsChang-Heok Soh, James M Oleske, Michael T Brady, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|March 1, 1997
Effect of pregnancy and zidovudine therapy on viral load in HIV-1-infected womenA J Melvin, S K Burchett, D H Watts, et al.
The Journal of Infectious Diseases|October 11, 2011
Maternal cytomegalovirus-specific immune responses and symptomatic postnatal cytomegalovirus transmission in very low-birth-weight preterm infantsElizabeth P Ehlinger, Emily M Webster, Helen H Kang, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 9, 2013
Pharmacokinetics of an increased atazanavir dose with and without tenofovir during the third trimester of pregnancyRegis Kreitchmann, Brookie M Best, Jiajia Wang, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 26, 2009
Potential confounding of the association between exposure to nucleoside analogues and mitochondrial dysfunction in HIV-uninfected and indeterminate infantsSusan B Brogly, Marc Foca, Jaime G Deville, et al.
HIV Medicine|September 18, 2008
Pharmacokinetics of new 625 mg nelfinavir formulation during pregnancy and postpartumJ S Read, B M Best, A M Stek, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 28, 2014
Raltegravir pharmacokinetics during pregnancyD Heather Watts, Alice Stek, Brookie M Best, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 27, 2016
Pharmacokinetics of Rilpivirine in HIV-Infected Pregnant WomenAnna H Tran, Brookie M Best, Alice Stek, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Journal of Acquired Immune Deficiency Syndromes (1999)|May 8, 2015
Pharmacokinetics of Once Versus Twice Daily Darunavir in Pregnant HIV-Infected WomenAlice Stek, Brookie M Best, Jiajia Wang, et al.
The Journal of Infectious Diseases|December 1, 1996
Application of the polymerase chain reaction to the diagnosis and management of neonatal herpes simplex virus disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study GroupD W Kimberlin, F D Lakeman, A M Arvin, et al.
Lancet (London, England)|December 31, 2003
Long-term effects of protease-inhibitor-based combination therapy on CD4 T-cell recovery in HIV-1-infected children and adolescentsChang-Heok Soh, James M Oleske, Michael T Brady, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|March 1, 1997
Effect of pregnancy and zidovudine therapy on viral load in HIV-1-infected womenA J Melvin, S K Burchett, D H Watts, et al.
The Journal of Infectious Diseases|October 11, 2011
Maternal cytomegalovirus-specific immune responses and symptomatic postnatal cytomegalovirus transmission in very low-birth-weight preterm infantsElizabeth P Ehlinger, Emily M Webster, Helen H Kang, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 9, 2013
Pharmacokinetics of an increased atazanavir dose with and without tenofovir during the third trimester of pregnancyRegis Kreitchmann, Brookie M Best, Jiajia Wang, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 26, 2009
Potential confounding of the association between exposure to nucleoside analogues and mitochondrial dysfunction in HIV-uninfected and indeterminate infantsSusan B Brogly, Marc Foca, Jaime G Deville, et al.
HIV Medicine|September 18, 2008
Pharmacokinetics of new 625 mg nelfinavir formulation during pregnancy and postpartumJ S Read, B M Best, A M Stek, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 28, 2014
Raltegravir pharmacokinetics during pregnancyD Heather Watts, Alice Stek, Brookie M Best, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 27, 2016
Pharmacokinetics of Rilpivirine in HIV-Infected Pregnant WomenAnna H Tran, Brookie M Best, Alice Stek, et al.
Pageof 8